eli lilly clinical trials retatrutide Lilly's triple agonist achieves 16.8% weight loss in phase 3 trial Eli Lilly's trial of obesity

Experimental models suggest that TB-500associated pathways are closely linked to actin dynamics, enabling repair-relevant cells such as keratinocytes and endothelial cells to reorganize cytoskeletal structures and migrate efficiently across wound margins

Furthermore, the research supporting systemic (injectable) GHK-Cu for tendon or joint repair in healthy humans is almost non-existent, relying entirely on animal models and anecdotal reports

& Entwistle, G

The oral GLP-1 currently available: the Wegovy pill The Wegovy pill (oral semaglutide 25 mg) was approved by the FDA in December 2025 and launched in the US in January 2026